Department of Cardiac Surgery, Beijing Anzhen Hospital,Capital Medical University, Beijing, China.
Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Front Endocrinol (Lausanne). 2022 Apr 29;13:844787. doi: 10.3389/fendo.2022.844787. eCollection 2022.
Subclinical hypothyroidism can negatively affect the cardiovascular system and increase the risk of mortality, especially for individuals with thyroid-stimulating hormone (TSH) levels above 10 mU/L. We investigated the relationship between high-TSH subclinical hypothyroidism and postoperative mortality in acute type A aortic dissection (ATAAD) patients.
We enrolled 146 patients with ATAAD who underwent aortic surgery in Beijing Anzhen Hospital from July 2016 to November 2018. Thyroid hormone levels were obtained before surgery, and participants were divided into a ≥10mU/L TSH level group and a <10mU/L level group. Cox proportional hazard regression and subgroup analysis were conducted to examine the association of preoperative high-TSH subclinical hypothyroidism with postoperative mortality.
Participants with preoperative high-TSH (≥10mU/L) subclinical hypothyroidism tended to have longer hospitalization stays after surgery [16.0 (IQR 11.0-21.0) days vs 12.5 (IQR 8.0-16.0) days, P=0.001]. During the first 30 days after operation, 15 of 146 patients died (10.3%); during a median of 3.16 (IQR 1.76-4.56) years of follow-up, 24 patients died (16.4%). Cox proportional hazard regression showed that preoperative high-TSH subclinical hypothyroidism was independently associated with 30-day mortality (HR=6.2, 95% CI, 1.7-22.0, P=0.005) and postoperative mortality after adjusting for age, sex, BMI, hypertension, ejection fraction, diabetes and history of PCI (HR=3.4, 95% CI, 1.4-8.0, P=0.005).
This study showed that preoperative high-TSH subclinical hypothyroidism was an independent predictor of postoperative mortality in ATAAD patients who underwent aortic surgery.
亚临床甲状腺功能减退症可对心血管系统产生负面影响,并增加死亡率,尤其是促甲状腺激素(TSH)水平超过 10mU/L 的患者。我们研究了高 TSH 亚临床甲状腺功能减退症与急性 A 型主动脉夹层(ATAAD)患者术后死亡率之间的关系。
我们纳入了 2016 年 7 月至 2018 年 11 月在北京安贞医院接受主动脉手术的 146 名 ATAAD 患者。在术前获取甲状腺激素水平,并将患者分为 TSH 水平≥10mU/L 组和<10mU/L 组。采用 Cox 比例风险回归和亚组分析来检验术前高 TSH 亚临床甲状腺功能减退症与术后死亡率之间的关系。
术前高 TSH(≥10mU/L)亚临床甲状腺功能减退症患者术后住院时间较长[16.0(IQR 11.0-21.0)天 vs 12.5(IQR 8.0-16.0)天,P=0.001]。术后 30 天内,146 例患者中有 15 例死亡(10.3%);在中位随访 3.16(IQR 1.76-4.56)年后,24 例患者死亡(16.4%)。Cox 比例风险回归显示,在校正年龄、性别、BMI、高血压、射血分数、糖尿病和 PCI 史后,术前高 TSH 亚临床甲状腺功能减退症与 30 天死亡率(HR=6.2,95%CI,1.7-22.0,P=0.005)和术后死亡率相关(HR=3.4,95%CI,1.4-8.0,P=0.005)。
本研究表明,术前高 TSH 亚临床甲状腺功能减退症是接受主动脉手术的 ATAAD 患者术后死亡率的独立预测因素。